$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2016-05-12 AccNo: 0001193125-16-588027 Size: 586 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.01: Completion of Acquisition or Disposition of AssetsItem 3.02: Unregistered Sales of Equity SecuritiesItem 3.03: Material Modifications 网页链接